Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,547 | -11,290 | -7,308 | -3,895 | -2,468 |
| Depreciation Amortization | 31 | 60 | 44 | 23 | 11 |
| Accounts receivable | 79 | -1,697 | -4,235 | -3,427 | N/A |
| Accounts payable and accrued liabilities | 261 | -169 | 217 | 444 | -18 |
| Other Working Capital | 384 | -1,340 | -3,928 | -3,194 | -272 |
| Other Operating Activity | -196 | 3,456 | 5,061 | 3,711 | 264 |
| Operating Cash Flow | $-3,988 | $-10,980 | $-10,149 | $-6,338 | $-2,483 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,190 | -3,766 | -3,296 | 0 | N/A |
| PPE Investments | -2 | -200 | -168 | -34 | -10 |
| Other Investing Activity | 0 | -44 | -40 | -10 | -10 |
| Investing Cash Flow | $-1,192 | $-4,010 | $-3,504 | $-44 | $-20 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | -2,005 | -1,802 | -837 | N/A |
| Other Financing Activity | -98 | 43,675 | 43,679 | 43,684 | 43,678 |
| Financing Cash Flow | $-98 | $41,670 | $41,877 | $42,847 | $43,678 |
| Beginning Cash Position | 29,294 | 2,610 | 2,616 | 2,616 | 2,616 |
| End Cash Position | 24,016 | 29,290 | 30,840 | 39,081 | 43,791 |
| Net Cash Flow | $-5,278 | $26,670 | $28,224 | $36,465 | $41,175 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,988 | -10,980 | -10,149 | -6,338 | -2,483 |
| Capital Expenditure | -2 | -208 | -168 | -34 | -10 |
| Free Cash Flow | -3,990 | -11,188 | -10,317 | -6,372 | -2,493 |